Skip to Main Content

Paper Details

Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition.
Leukemia and Lymphoma
0
2021
PI3K, glucagon receptor, hyperglycemia, tumor

Datasets

Release 1.2